世界の季節性インフルエンザワクチン治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Seasonal Influenza Vaccines Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5146
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、季節性インフルエンザワクチン治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小児科、青年期、成人、高齢者）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・季節性インフルエンザワクチン治療薬の市場動向
・企業の競争状況、市場シェア
・季節性インフルエンザワクチン治療薬の種類別市場規模（小児科、青年期、成人、高齢者）
・季節性インフルエンザワクチン治療薬の用途別市場規模（病院、診療所、その他）
・季節性インフルエンザワクチン治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・季節性インフルエンザワクチン治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・季節性インフルエンザワクチン治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・季節性インフルエンザワクチン治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・季節性インフルエンザワクチン治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GSK、Novartis、CSL、MedImmune、Sanofi-Pasteur、Solvay、Sinovac Biotech、Hualun Biologicals）
・結論

Influenza vaccine typically known as flu shot and is used for protection against influenza virus.

Market Analysis and Insights: Global Seasonal Influenza Vaccines Therapeutics Market
The global Seasonal Influenza Vaccines Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Influenza Vaccines Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Influenza Vaccines Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Influenza Vaccines Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Influenza Vaccines Therapeutics market.

Global Seasonal Influenza Vaccines Therapeutics Scope and Market Size
Seasonal Influenza Vaccines Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccines Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Paediatrics
Adolescence
Adults
Elderly

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Sinovac Biotech
Hualun Biologicals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2016-2027)
2.2 Seasonal Influenza Vaccines Therapeutics Growth Trends by Regions
2.2.1 Seasonal Influenza Vaccines Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Seasonal Influenza Vaccines Therapeutics Industry Dynamic
2.3.1 Seasonal Influenza Vaccines Therapeutics Market Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Influenza Vaccines Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Seasonal Influenza Vaccines Therapeutics Revenue
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
3.5 Seasonal Influenza Vaccines Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027)

5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type
8.2.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.4.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
9.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type
9.2.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application
9.3.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.4.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type
10.2.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.4.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.3.5 CSL Recent Development
11.4 MedImmune
11.4.1 MedImmune Company Details
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.4.5 MedImmune Recent Development
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Details
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.5.5 Sanofi-Pasteur Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.6.5 Solvay Recent Development
11.7 Sinovac Biotech
11.7.1 Sinovac Biotech Company Details
11.7.2 Sinovac Biotech Business Overview
11.7.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.7.5 Sinovac Biotech Recent Development
11.8 Hualun Biologicals
11.8.1 Hualun Biologicals Company Details
11.8.2 Hualun Biologicals Business Overview
11.8.3 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Hualun Biologicals Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
11.8.5 Hualun Biologicals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Paediatrics
Table 3. Key Players of Adolescence
Table 4. Key Players of Adults
Table 5. Key Players of Elderly
Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends
Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers
Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges
Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints
Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020)
Table 19. Ranking of Global Top Seasonal Influenza Vaccines Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
Table 23. Date of Enter into Seasonal Influenza Vaccines Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Seasonal Influenza Vaccines Therapeutics Product
Table 66. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 67. GSK Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Seasonal Influenza Vaccines Therapeutics Product
Table 71. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. CSL Company Details
Table 74. CSL Business Overview
Table 75. CSL Seasonal Influenza Vaccines Therapeutics Product
Table 76. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 77. CSL Recent Development
Table 78. MedImmune Company Details
Table 79. MedImmune Business Overview
Table 80. MedImmune Seasonal Influenza Vaccines Therapeutics Product
Table 81. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 82. MedImmune Recent Development
Table 83. Sanofi-Pasteur Company Details
Table 84. Sanofi-Pasteur Business Overview
Table 85. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product
Table 86. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Sanofi-Pasteur Recent Development
Table 88. Solvay Company Details
Table 89. Solvay Business Overview
Table 90. Solvay Seasonal Influenza Vaccines Therapeutics Product
Table 91. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Solvay Recent Development
Table 93. Sinovac Biotech Company Details
Table 94. Sinovac Biotech Business Overview
Table 95. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product
Table 96. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Sinovac Biotech Recent Development
Table 98. Hualun Biologicals Company Details
Table 99. Hualun Biologicals Business Overview
Table 100. Hualun Biologicals Revenue in Seasonal Influenza Vaccines Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Hualun Biologicals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Paediatrics Features
Figure 3. Adolescence Features
Figure 4. Adults Features
Figure 5. Elderly Features
Figure 6. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Seasonal Influenza Vaccines Therapeutics Report Years Considered
Figure 11. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2020
Figure 16. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2020
Figure 18. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2016-2027)
Figure 40. China Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 61. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 62. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 63. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 64. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 65. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 66. Hualun Biologicals Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Seasonal Influenza Vaccines Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z12326 2021年4月 100Pages
当調査資料では、季節性インフルエンザワクチン治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。季節性インフルエンザワクチン治療薬の種類別市場規模（小児、青年、成人、高齢者）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨ...

世界の季節性インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別

Global Seasonal Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z12325 2021年4月 107Pages
当調査資料では、季節性インフルエンザワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。季節性インフルエンザワクチンの種類別市場規模（タイプA（H1N1）、タイプA（H3N2）、タイプB）、用途別市場規模（小児、青年、成人、高齢者）、地域別市場規模...

世界のmRNAがんワクチン・治療薬市場規模・現状・予測（2021年-2027年）

Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3935 2021年4月 92Pages
QYResearch社発行の本調査資料では、mRNAがんワクチン・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん治療用標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途...

世界の新型コロナウイルス感染症ワクチン・治療薬市場規模・現状・予測（2021年-2027年）

Global COVID-19 Vaccines & Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z1634 2021年4月 90Pages
QYResearch社発行の本調査資料では、新型コロナウイルス感染症ワクチン・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（新型コロナウイルス感染症ワクチン、新型コロナウイルス感染症治療薬）、用途別市場規模（子供、成人）、主要地域別市場...

世界のRNAベース治療薬＆ワクチン市場規模・現状・予測（2021年-2027年）

Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2021-2027
QYR2104Z5056 2021年4月 94Pages
QYResearch社発行の本調査資料では、RNAベース治療薬＆ワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RNAベース治療薬、RNAベースワクチン）、用途別市場規模（腫瘍、免疫、眼科、心血管疾患、感染症、遺伝病、その他）、主要地域...

季節性インフルエンザワクチンの世界市場2020年：分析と予測（～2025年）

Seasonal Influenza Vaccine Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Product Type
MR2104PF477 2021年4月 80Pages
Prof Research社の本調査レポートでは、季節性インフルエンザワクチンの世界市場について調査・分析し、季節性インフルエンザワクチンのグローバル市場概要、市場動向、産業構造、貿易動向（輸出・輸入）、地域別市場規模（北米、南米、アジア、ヨーロッパ、中東・アフリカ）、世界の市場規模予測、セグメント...

世界のワクチン配達市場規模・現状・予測（2021年-2027年）

Global Vaccines Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z5856 2021年4月 92Pages
QYResearch社発行の本調査資料では、ワクチン配達のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物学ベクター、化学担体、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のHIVワクチン市場規模・現状・予測（2021年-2027年）

Global HIV Vaccines Market Size, Status and Forecast 2021-2027
QYR2104Z2861 2021年4月 99Pages
QYResearch社発行の本調査資料では、HIVワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フェーズI、フェーズII、フェーズIII）、用途別市場規模（研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のHIVワクチン市場規模・現状・予測（2021年-2027年）

世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年）

Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5145 2021年4月 95Pages
QYResearch社発行の本調査資料では、季節性情動障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、医薬品、心理療法、カウンセリング、その他）、用途別市場規模（病院、診療所、医学研究センター、その他）、主要地域別市場規模（北...

世界の季節性インフルエンザワクチン治療薬市場 2021：企業別、地域別、種類・用途別 The Seasonal Influenza Vaccines Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
世界の季節性インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Seasonal Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
季節性インフルエンザワクチンの世界市場2020年：分析と予測（～2025年） This report describes the global market size of Seasonal Influenza Vaccine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 20…
世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…
世界の抗インフルエンザ薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-influenza Drugs Market The global Anti-influenza Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…